Glucagon-Like Peptide 1 and Glucose-Dependent Insulinotropic Polypeptide Analogues as Novel Treatments for Alzheimer’s and Parkinson’s Disease
Cardiovascular Endocrinology
doi 10.1097/xce.0000000000000087
Full Text
Open PDFAbstract
Available in full text
Date
September 1, 2016
Authors
Publisher
Ovid Technologies (Wolters Kluwer Health)